SCHEMBL1015776

SCHEMBL1015776

Nc1cc(-c2ccoc2)ccc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.45
MAP4K4 O95819 1/20 0.42
HDAC2 Q92769 1/20 0.42
LMNA P02545 3/20 0.41
CYP2C19 P33261 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
ESR2 Q92731 1/20 0.41
PARP1 P09874 1/20 0.40
TPI1 P60174 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
CHEK1 O14757 1/20 0.40
TOP2A P11388 1/20 0.40
CYP1A1 P04798 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HDAC1 Q13547 1/20 0.37
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8181149 0.81 TDP1 (0.55) MAP4K4LMNACYP2C19TDP1HSD17B10
SCHEMBL1015956 0.77 ALDH1A1 (0.44) ERN1HDAC2LMNACYP2C19TDP1
SCHEMBL3135893 0.73 ALOX15 (0.65) ERN1HDAC2LMNATDP1HSD17B10
SCHEMBL12121819 0.73 ERN1 (0.61) ERN1HDAC2LMNACYP2C19HSD17B10
SCHEMBL6775373 0.73 ADORA1 (0.40) ERN1HDAC2LMNACYP2C19TDP1
SCHEMBL19475523 0.73 ALDH1A1 (0.48) ERN1HDAC2LMNATDP1HSD17B10
SCHEMBL28244759 0.73 PGR (0.44) ERN1ESR2PARP1TPI1PARP2
SCHEMBL15234491 0.73 CYP1A1 (0.51) MAP4K4HDAC2LMNACYP2C19TDP1
SCHEMBL3789413 0.73 TAAR1 (0.54) MAP4K4LMNACYP2C19TDP1HSD17B10
SCHEMBL15234523 0.73 CYP1A1 (0.51) MAP4K4HDAC2LMNACYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ERN1 1102/4885MAP4K4 2958/4885HDAC2 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.